Answers are grounded in this paper and cite their sources.
Systemic lupus erythematosus is associated with immune-mediated damage to multiple organs and increased mortality. Hydroxychloroquine is first-line therapy and reduces disease activity, morbidity, and mortality. When needed, additional immunosuppressive and biologic therapies include azathioprine, mycophenolate mofetil, cyclophosphamide, belimumab, voclosporin, and anifrolumab.
No takes yet. Share an insight, caveat, or question.
Siegel et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: